TMS 10 Years Later

I'm always a fan of new treatment technologies. Each new treatment technology (whether a new medication, new clinical practice, new device, new app) represents more options for consumers and pushes competition (both in terms of outcomes and price).

But any new treatment approach has an uphill climb to get to widespread adoption. The reasons are many—and we've written about them before (see Going 'Over The Rainbow' To Tech Oz and The Snags In 'Speed To Market' For Health Care Innovations). Even for a treatment technology as basic as telehealth, only 18% of consumers have participated in an . . .